PEDONE, CARLO
 Distribuzione geografica
Continente #
AS - Asia 4.994
NA - Nord America 2.948
SA - Sud America 1.001
EU - Europa 898
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 80
OC - Oceania 9
Totale 10.053
Nazione #
US - Stati Uniti d'America 2.808
SG - Singapore 2.145
CN - Cina 1.117
BR - Brasile 770
VN - Vietnam 524
HK - Hong Kong 491
FR - Francia 328
IT - Italia 254
KR - Corea 230
BD - Bangladesh 119
AR - Argentina 69
IN - India 69
GB - Regno Unito 64
JP - Giappone 59
CA - Canada 55
NL - Olanda 50
ID - Indonesia 48
CO - Colombia 44
EC - Ecuador 44
DE - Germania 40
MX - Messico 36
FI - Finlandia 29
IL - Israele 27
VE - Venezuela 25
IQ - Iraq 23
UA - Ucraina 23
ES - Italia 20
ZA - Sudafrica 19
MA - Marocco 17
MY - Malesia 17
PK - Pakistan 16
PY - Paraguay 16
TR - Turchia 15
CL - Cile 13
PL - Polonia 13
SA - Arabia Saudita 13
RU - Federazione Russa 12
AE - Emirati Arabi Uniti 11
PE - Perù 11
PH - Filippine 11
KE - Kenya 10
NP - Nepal 10
AT - Austria 8
CR - Costa Rica 8
TN - Tunisia 8
UZ - Uzbekistan 8
JM - Giamaica 7
KZ - Kazakistan 7
EG - Egitto 6
JO - Giordania 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
DZ - Algeria 5
RO - Romania 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GR - Grecia 4
HN - Honduras 4
IE - Irlanda 4
LB - Libano 4
NG - Nigeria 4
NI - Nicaragua 4
SE - Svezia 4
TH - Thailandia 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
GP - Guadalupe 3
NZ - Nuova Zelanda 3
OM - Oman 3
PR - Porto Rico 3
PT - Portogallo 3
SC - Seychelles 3
TW - Taiwan 3
BE - Belgio 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CU - Cuba 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
LT - Lituania 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
CH - Svizzera 1
CM - Camerun 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
Totale 9.913
Città #
Singapore 1.292
Santa Clara 747
Hefei 500
Hong Kong 482
San Jose 340
Lauterbourg 266
Seoul 229
Ashburn 205
Ho Chi Minh City 182
Beijing 177
Hanoi 135
Los Angeles 77
São Paulo 66
Dallas 65
Buffalo 52
New York 34
Chicago 29
Helsinki 29
Naples 27
Rio de Janeiro 27
Minamishinagawa 26
Tokyo 26
Rome 24
Bengaluru 22
Da Nang 21
Haiphong 21
Milan 21
Council Bluffs 19
Frankfurt am Main 18
Guayaquil 18
Guangzhou 17
Miami 17
Brasília 16
Phoenix 16
Figino 15
Baltimore 13
Dhaka 13
Houston 13
Orem 13
Philadelphia 13
Charlotte 12
Florence 12
Montreal 12
Shanghai 12
Asunción 11
Atlanta 11
Belo Horizonte 11
Brooklyn 11
Denver 11
Quito 11
Salvador 11
Toronto 11
Baghdad 10
Biên Hòa 10
Curitiba 10
Detroit 10
Hải Dương 10
Manchester 10
Tampa 10
The Bronx 10
Warsaw 10
Boardman 9
Cleveland 9
Guarulhos 9
London 9
Louisville 9
Queens 9
Bogotá 8
Cincinnati 8
Nairobi 8
Newark 8
Nha Trang 8
Pittsburgh 8
Ribeirão Preto 8
Boston 7
Campinas 7
Can Tho 7
Goiânia 7
Jakarta 7
Lima 7
Nuremberg 7
Orlando 7
Osasco 7
Phủ Lý 7
Tashkent 7
Thái Bình 7
Amman 6
Anápolis 6
Bình Dương Province 6
Casablanca 6
Elk Grove Village 6
Joinville 6
Kansas City 6
Kathmandu 6
Kuala Lumpur 6
Milwaukee 6
Porto Alegre 6
Riyadh 6
Turin 6
Arlington 5
Totale 5.826
Nome #
IN VITRO AND IN VIVO CHARACTERIZATION OF INDIUM-111 AND TECHNETIUM-99M LABELED CCK-8 DERIVATIVES FOR CCK-B RECEPTOR IMAGING. 102
Sleep disorders during the COVID-19 pandemic: Results from the second phase of web-based EPICOVID19 study 93
Evidences for supramolecularorganization of nucleopeptides: synthesis, spectroscopic and biological studiesof a novel dithymine L-serine tetrapeptide. 88
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. 82
THE CRYSTAL STRUCTURE OF HCA I/TOPIRAMATE COMPLEX PROVIDES USEFUL INSIGHTS INTO RATIONAL DRUG DESIGN OF ANTI-OBESITY DRUGS 77
Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. 77
Pathophysiological changes of gram-negative bacterial infection can be reproduced by a synthetic peptide mimicking loop L7 sequence of Haemophilus influenzae porin 76
Design of VEGF binder miniproteins 72
Evidences for complex formation between L-dabPNA and aegPNA 72
The Identification and Characterisation of Fusogenic Domains in Herpesvirus Glycoprotein B Molecules 72
Self-association regions in the CARD of Bcl-10 72
IN VITRO AND IN VIVO EVALUATION OF 111In-DTPAGlu-G-CCK8 FOR CHOLECYSTOKININ-B RECEPTOR IMAGING. 72
Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. 69
Stability of single sheet GNNQQNY aggregates analyzed by replica exchange molecular dynamics: antiparallel versus parallel association 69
The unusual helix stability of a VEGF mimetic peptide 66
Structural characterization of the helix stability of a de novo engineered VEGF mimicking peptide with relevant biological activity 61
Molecular dynamics simulation in vacuo and in solution of [aib5, 6-d-ala8] cyclolinopeptide a: A conformational and comparative study 60
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 59
DNA-based strategies for blocking HMGB1 cytokine activity: design,synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes 59
Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor 58
Polypeptide Antagonists of IgE-FceRI interaction 58
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 58
Native expression and purification of hormone-sensitive lipase from Psychrobacter sp. TA144 enhances protein stability and activity 54
The Arabidopsis SUPERMAN protein is able to specifically bind DNA through its single Cys2-His2 zinc finger motif 53
Synthetic peptides mimicking the interleukin-6/gp130 interaction: A two-helix bundle system. Design and confirmational studies 53
Synthesis and characterization of new gamma-nucleo peptides based on a diaminobutyric acid moiety 52
Aß(25-35) and its C-and/or N-blocked derivatives: copper driven folding feautures and neurotoxicity 52
Gold Nanoparticles Capped by a GC-Containing Peptide Functionalized with an RGD Motif for Integrin Targeting. 51
Expression, purification and partial characterization of the Kruppel-associated box (KRAB) from the human ZNF2 protein 50
Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells 50
A NOVEL AND HIGHLY SELECTIVE IgE-BINDING PEPTIDE WITH ANTI-ALLERGIC PROPERTIES: AN SPR AND CELL-BASED STUDY 50
Naposomes: A New Class of Peptide Derivatized Target Selective Multimodal Nanoparticles for Imaging and Therapeutic Applications 49
Thermodynamic Studies on PNA and PNA/DNA Dendrimer Formation 49
Functional and structural features of the oxyanion hole in a thermophilic esterase from Alicyclobacillus acidocaldarius 49
Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor. 48
dabPNA: design, synthesis and nucleic acids binding studies. 48
18FLUORO-ACTIVE-PEPTIDES: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 48
bases of M. tuberculosis daughter cell separation 47
Evaluation of the anti-angiogenic properties of the new selective alpha(V)beta(3) integrin antagonist RGDechiHCit 46
Synthesis of novel MMT/acyl-protected nucleo alanine monomers for the preparation of DNA/alanyl-PNA chimeras 45
Identification of Inhibitors of Protein-Protein Interactions Through the Screening of Simplified Combinatorial Peptide Libraries. Breaking Away: Proceedings of the 21st American Peptide Symposium Michal Lebl 45
Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-κB binding sites 45
31st BIOMEDICAL NANOTECHNOLOGY: PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 45
Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II 45
Supramolecular aggregates containing lipophilic Gd(III) complexes as contrast agents in MRI 45
Structural and functional insights into I?B-?/HIV-1Tat interaction 45
A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots 45
Supramolecular aggregates derivatized by CCK8 peptide as selective nanocarriers for drug delivery 44
Synthesis, biological evaluation andsupramolecular assembly of novel analogues of peptidyl nucleosides 43
Evidences for complex formation between l-dabPNA and aegPNA 43
Preliminary studies on noncovalent hyperbranched polymers based on PNA and DNA building blocks 43
Discovery ofsmall peptide antagonists of PED/PEA15-D4? interaction from simplifiedcombinatorial libraries 43
Sintesi e studi di interazione con acidi nucleici di un nuovo peptide cationico 43
Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions 42
In vivo biological activity of a ApoA-I mimetic peptide 42
A CUL3-DERIVED PEPTIDE BINDING DIFFERENT MEMBERS OF THE KCTD FAMILY 42
Bioactive peptides as target-selective delivery tools of high relaxivity MRI contrast agents based on amphiphilic Gadolinium complexes 42
Synthesis, characterization and hybridization studies of new nucleo-? -peptides based on diaminobutyric acid 42
Fluorimetric investigation and molecular dynamics simulation on interaction between prion protein helix: And tetracycline 41
Bent oligonucleotide duplexes as HMGB1 inhibitors: a comparative study 41
Crystal and molecular structure of β-cyclodextrins functionalized with the anti-inflammatory drug etodolac 41
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 41
Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. 41
Bioactive Peptides: X-ray and NMR Conformational Study of [Aib5,6-D-Ala8]cyclolinopeptide A 41
Peptides from Royal Jelly: studies on the antimicrobial activity of jelleins, jelleins analogs and synergy with temporins 40
Bioinorganic aspects of angiogenesis 40
Exploring the catalytic mechanism of the first dimeric Bcp: Functional, structural and docking analyses of Bcp4 from Sulfolobus solfataricus. 39
Structure/function of KRAB repression domains: Structural properties of KRAB modules inferred from hydrodynamic, circular dichroism, and FTIR spectroscopic analyses 39
Peptide antagonists of the PED-hPLD1 binding 39
Evidence for a Role of the Membrane-proximal Region of Herpes Simplex Virus Type 1 Glycoprotein H in Membrane Fusion and Virus Inhibition 39
Relevance of the amino acid conversions L144R (Zaragoza) and L159P (Zavalla)in the Apolipoprotein A-I binding site for Haptoglobin 39
Synthesis and characterization of new ³ sulphate PNA 39
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 39
PNA-mediated alteration of mRNA splicing 38
A substrate-induced switch in the reaction mechanism of a thermophilic esterase. Kinetic evidences and structutal basis 38
Peptide Structure and Analysis 38
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 37
Synthetic analogs of human b -defensins having antimicrobial, antiviral, and chemotactic activity 37
Structural Determinants of the Unusual Helix Stability of a De Novo Engineered Vascular Endothelial Growth Factor (VEGF) Mimicking Peptide 37
Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity 37
RNA-binding and viral reverse transcriptase inhibitory activity of a novelcationic diamino acid-based peptide. 37
Covalent immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters 37
Insights into the structural basis of the GADD45beta -mediated inactivation of the JNK kinase, MKK7/JNKK2 37
β‐Alanine containing peptides: A novel molecular tool for the design of γ‐turns 37
Structure and stability of amyloid-like aggregates investigated by molecular dynamics 36
NMR strcutural characterization of a bioactive b-hairpin peptide and its interaction with VEGFR1D2 36
A novel member of the protein disulfide oxidoreductase family from Aeropyrum pernix K1: structure, function and electrostatics. 36
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the resuscitation promoting factor interacting protein RipA from M. tuberculosis 36
Fluorimetric investigation and Molecular Dynamics simulation on interactions between Prion Protein Helix 2 and Tetracycline 36
Molecular recognition between neurotrophins and their receptors: a molecular dynamics approach 35
A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library 35
Peptides reproducing the ApoA-I 141-164 region: Studies on Hpt recognition 35
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 35
Assignment of the binding site for haptoglobin on apolipoprotein A-I 35
From nature, through chemical synthesis, towards the use of nucleobase-containing amino acids in biotechnology 35
NMR backbone dynamics studies of human PED/PEA-15 outline protein functional sites 35
Structure-activity relationships in peptides: From modelling to rational drug design 35
Evidences of complex formation between DABA-based nucleo-gamma-peptides with alternate configuration backbone 35
PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 34
Structure-Activity Relationships in Peptides 34
Totale 4.822
Categoria #
all - tutte 36.973
article - articoli 21.136
book - libri 226
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 497
Totale 58.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024112 0 0 0 0 0 0 0 0 3 30 77 2
2024/20253.329 18 20 274 208 695 46 60 80 34 76 910 908
2025/20265.342 261 604 612 804 947 106 886 308 240 281 172 121
2026/20271.270 271 305 694 0 0 0 0 0 0 0 0 0
Totale 10.053